Hank Green talks with us about why research and development make the prescription drug development process long...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Speaking at the 2026 J.P. Morgan Healthcare Conference, Hogan Lovells global regulatory partners Elizabeth Jungman and Brian ...

Averhealth’s lab practices have been faulted by its own accreditor, and the company has been targeted in lawsuits and dropped ...

Resolving business-related disputes swiftly, protecting the legitimate rights of market participants, and nurturing a healthy ...